Ketoftil (Ketotifen Hydrogen Fumarate)

Ketotifen hydrogen fumarate works by stabilising mast cells and blocking H1 histamine receptors on the ocular surface. This dual action prevents the release of histamine and other inflammatory mediators, thereby decreasing the allergic response that causes eye irritation and itching.

The specific dosing regimen for Ketoftil is determined by the prescribing clinician. Typically, one drop is instilled in the affected eye(s) as directed, and the frequency is adjusted based on the severity of symptoms and patient response.

Safety data for ketotifen hydrogen fumarate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Ketoftil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoftil (ketotifen) offers both H1‑receptor blockade and mast‑cell stabilisation, whereas many alternatives such as olopatadine primarily provide H1 antagonism. This dual mechanism can give longer‑lasting relief for some patients, though individual response varies and choice should be guided by clinical judgement.

Ketoftil should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from direct light and moisture. Do not freeze the solution, and keep the cap tightly closed when not in use.

Ketoftil is administered as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a pocket, and place the prescribed number of drops into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, persistent visual loss, and secondary ocular infections. Patients should seek immediate medical attention if they experience sudden vision changes, intense eye pain, swelling of the face or throat, or signs of infection.

Ketoftil should not be used by individuals with a known hypersensitivity to ketotifen hydrogen fumarate or any excipients in the formulation. It is also contraindicated in patients with active ocular infections until the infection is resolved, and caution is advised for contact‑lens wearers.